欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DE/H/0386/003
药品名称
Votum 40 mg
活性成分
olmesartan medoxomil 40.0 mg
剂型
Film-coated tablet
上市许可持有人
Berlin-Chemie AG Glienicker Weg 125 12489 Berlin Germany
参考成员国 - 产品名称
Germany (DE)
互认成员国 - 产品名称
Belgium (BE)
Luxembourg (LU)
Ireland (IE)
Austria (AT)
Mencord 40 mg - Filmtabletten
France (FR)
Spain (ES)
Portugal (PT)
Italy (IT)
Greece (GR)
Poland (PL)
Cyprus (CY)
Czechia (CZ)
Slovenia (SI)
Malta (MT)
许可日期
2003/03/30
最近更新日期
2024/06/20
药物ATC编码
C09CA08 olmesartan medoxomil
申请类型
TypeLevel1:
New Active Substance
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Full Dossier Article 4.8 Di 65/65
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Product Information
|
final-common-SPC-0386-046
Date of last change:2017/06/06
Final Product Information
|
final-common-LboP-0386-046
Date of last change:2017/06/06
Final Product Information
|
final-common-PL-0386-046
Date of last change:2017/06/06
Final PL
|
plen-Votum-II_SmPC_final_Day 90_201304_highlighted
Date of last change:2013/04/24
Final SPC
|
spcen-Votum-II_SmPC_final_Day 90_201304_highlighted
Date of last change:2013/04/24
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase